Industry Research Reports
Global Mucin 1 Market Insights, Forecast to 2030
Industry: Pharma & Healthcare
Published Date: 2024-04-26
Pages: 87 Pages
Report ld: 3083026
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Mucin 1 market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Mucin 1 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Mucin 1 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Mucin 1 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Mucin 1 include Akshaya Bio Inc, Bavarian Nordic A/S, Boehringer Ingelheim GmbH, Etubics Corp, GeoVax Labs Inc, Merck KGaA, Minerva Biotechnologies Corp, Transgene SA and Vaxil Bio Therapeutics Ltd, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Mucin 1, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Mucin 1, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Mucin 1, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mucin 1 sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Mucin 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Mucin 1 sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Akshaya Bio Inc, Bavarian Nordic A/S, Boehringer Ingelheim GmbH, Etubics Corp, GeoVax Labs Inc, Merck KGaA, Minerva Biotechnologies Corp, Transgene SA and Vaxil Bio Therapeutics Ltd, etc.
MARKET SEGMENTATION
By Company
- Akshaya Bio Inc
- Bavarian Nordic A/S
- Boehringer Ingelheim GmbH
- Etubics Corp
- GeoVax Labs Inc
- Merck KGaA
- Minerva Biotechnologies Corp
- Transgene SA
- Vaxil Bio Therapeutics Ltd
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- TG-4010
- GO-2032c
- ImMucin
- BI-1361849
- Others
Segment by Application
- Prostate Cancer
- Breast Cancer
- Colon Cancer
- Ovarian Cancer
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Mucin 1 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Mucin 1 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mucin 1 sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Mucin 1 Product Introduction
1.2 Market by Type
1.2.1 Global Mucin 1 Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 TG-4010
1.2.3 GO-2032c
1.2.4 ImMucin
1.2.5 BI-1361849
1.2.6 Others
1.3 Market by Application
1.3.1 Global Mucin 1 Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Colon Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Mucin 1 Sales Estimates and Forecasts 2019-2030
2.2 Global Mucin 1 Revenue by Region
2.2.1 Global Mucin 1 Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Mucin 1 Revenue by Region (2019-2024)
2.2.3 Global Mucin 1 Revenue by Region (2025-2030)
2.2.4 Global Mucin 1 Revenue Market Share by Region (2019-2030)
2.3 Global Mucin 1 Sales Estimates and Forecasts 2019-2030
2.4 Global Mucin 1 Sales by Region
2.4.1 Global Mucin 1 Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Mucin 1 Sales by Region (2019-2024)
2.4.3 Global Mucin 1 Sales by Region (2025-2030)
2.4.4 Global Mucin 1 Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Mucin 1 Sales by Manufacturers
3.1.1 Global Mucin 1 Sales by Manufacturers (2019-2024)
3.1.2 Global Mucin 1 Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mucin 1 in 2023
3.2 Global Mucin 1 Revenue by Manufacturers
3.2.1 Global Mucin 1 Revenue by Manufacturers (2019-2024)
3.2.2 Global Mucin 1 Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Mucin 1 Revenue in 2023
3.3 Global Key Players of Mucin 1, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Mucin 1 Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Mucin 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Mucin 1, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Mucin 1, Product Offered and Application
3.8 Global Key Manufacturers of Mucin 1, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mucin 1 Sales by Type
4.1.1 Global Mucin 1 Historical Sales by Type (2019-2024)
4.1.2 Global Mucin 1 Forecasted Sales by Type (2025-2030)
4.1.3 Global Mucin 1 Sales Market Share by Type (2019-2030)
4.2 Global Mucin 1 Revenue by Type
4.2.1 Global Mucin 1 Historical Revenue by Type (2019-2024)
4.2.2 Global Mucin 1 Forecasted Revenue by Type (2025-2030)
4.2.3 Global Mucin 1 Revenue Market Share by Type (2019-2030)
4.3 Global Mucin 1 Price by Type
4.3.1 Global Mucin 1 Price by Type (2019-2024)
4.3.2 Global Mucin 1 Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Mucin 1 Sales by Application
5.1.1 Global Mucin 1 Historical Sales by Application (2019-2024)
5.1.2 Global Mucin 1 Forecasted Sales by Application (2025-2030)
5.1.3 Global Mucin 1 Sales Market Share by Application (2019-2030)
5.2 Global Mucin 1 Revenue by Application
5.2.1 Global Mucin 1 Historical Revenue by Application (2019-2024)
5.2.2 Global Mucin 1 Forecasted Revenue by Application (2025-2030)
5.2.3 Global Mucin 1 Revenue Market Share by Application (2019-2030)
5.3 Global Mucin 1 Price by Application
5.3.1 Global Mucin 1 Price by Application (2019-2024)
5.3.2 Global Mucin 1 Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Mucin 1 Market Size by Type
6.1.1 US & Canada Mucin 1 Sales by Type (2019-2030)
6.1.2 US & Canada Mucin 1 Revenue by Type (2019-2030)
6.2 US & Canada Mucin 1 Market Size by Application
6.2.1 US & Canada Mucin 1 Sales by Application (2019-2030)
6.2.2 US & Canada Mucin 1 Revenue by Application (2019-2030)
6.3 US & Canada Mucin 1 Market Size by Country
6.3.1 US & Canada Mucin 1 Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Mucin 1 Sales by Country (2019-2030)
6.3.3 US & Canada Mucin 1 Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Mucin 1 Market Size by Type
7.1.1 Europe Mucin 1 Sales by Type (2019-2030)
7.1.2 Europe Mucin 1 Revenue by Type (2019-2030)
7.2 Europe Mucin 1 Market Size by Application
7.2.1 Europe Mucin 1 Sales by Application (2019-2030)
7.2.2 Europe Mucin 1 Revenue by Application (2019-2030)
7.3 Europe Mucin 1 Market Size by Country
7.3.1 Europe Mucin 1 Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Mucin 1 Sales by Country (2019-2030)
7.3.3 Europe Mucin 1 Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Mucin 1 Market Size
8.1.1 China Mucin 1 Sales (2019-2030)
8.1.2 China Mucin 1 Revenue (2019-2030)
8.2 China Mucin 1 Market Size by Application
8.2.1 China Mucin 1 Sales by Application (2019-2030)
8.2.2 China Mucin 1 Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Mucin 1 Market Size by Type
9.1.1 Asia Mucin 1 Sales by Type (2019-2030)
9.1.2 Asia Mucin 1 Revenue by Type (2019-2030)
9.2 Asia Mucin 1 Market Size by Application
9.2.1 Asia Mucin 1 Sales by Application (2019-2030)
9.2.2 Asia Mucin 1 Revenue by Application (2019-2030)
9.3 Asia Mucin 1 Sales by Region
9.3.1 Asia Mucin 1 Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Mucin 1 Revenue by Region (2019-2030)
9.3.3 Asia Mucin 1 Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Mucin 1 Market Size by Type
10.1.1 Middle East, Africa and Latin America Mucin 1 Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Mucin 1 Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Mucin 1 Market Size by Application
10.2.1 Middle East, Africa and Latin America Mucin 1 Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Mucin 1 Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Mucin 1 Sales by Country
10.3.1 Middle East, Africa and Latin America Mucin 1 Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Mucin 1 Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Mucin 1 Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Akshaya Bio Inc
11.1.1 Akshaya Bio Inc Company Information
11.1.2 Akshaya Bio Inc Overview
11.1.3 Akshaya Bio Inc Mucin 1 Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Akshaya Bio Inc Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Akshaya Bio Inc Recent Developments
11.2 Bavarian Nordic A/S
11.2.1 Bavarian Nordic A/S Company Information
11.2.2 Bavarian Nordic A/S Overview
11.2.3 Bavarian Nordic A/S Mucin 1 Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Bavarian Nordic A/S Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bavarian Nordic A/S Recent Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Information
11.3.2 Boehringer Ingelheim GmbH Overview
11.3.3 Boehringer Ingelheim GmbH Mucin 1 Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Boehringer Ingelheim GmbH Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim GmbH Recent Developments
11.4 Etubics Corp
11.4.1 Etubics Corp Company Information
11.4.2 Etubics Corp Overview
11.4.3 Etubics Corp Mucin 1 Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Etubics Corp Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Etubics Corp Recent Developments
11.5 GeoVax Labs Inc
11.5.1 GeoVax Labs Inc Company Information
11.5.2 GeoVax Labs Inc Overview
11.5.3 GeoVax Labs Inc Mucin 1 Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 GeoVax Labs Inc Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GeoVax Labs Inc Recent Developments
11.6 Merck KGaA
11.6.1 Merck KGaA Company Information
11.6.2 Merck KGaA Overview
11.6.3 Merck KGaA Mucin 1 Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Merck KGaA Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck KGaA Recent Developments
11.7 Minerva Biotechnologies Corp
11.7.1 Minerva Biotechnologies Corp Company Information
11.7.2 Minerva Biotechnologies Corp Overview
11.7.3 Minerva Biotechnologies Corp Mucin 1 Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Minerva Biotechnologies Corp Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Minerva Biotechnologies Corp Recent Developments
11.8 Transgene SA
11.8.1 Transgene SA Company Information
11.8.2 Transgene SA Overview
11.8.3 Transgene SA Mucin 1 Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Transgene SA Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Transgene SA Recent Developments
11.9 Vaxil Bio Therapeutics Ltd
11.9.1 Vaxil Bio Therapeutics Ltd Company Information
11.9.2 Vaxil Bio Therapeutics Ltd Overview
11.9.3 Vaxil Bio Therapeutics Ltd Mucin 1 Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Vaxil Bio Therapeutics Ltd Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vaxil Bio Therapeutics Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mucin 1 Industry Chain Analysis
12.2 Mucin 1 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mucin 1 Production Mode & Process
12.4 Mucin 1 Sales and Marketing
12.4.1 Mucin 1 Sales Channels
12.4.2 Mucin 1 Distributors
12.5 Mucin 1 Customers
13 Market Dynamics
13.1 Mucin 1 Industry Trends
13.2 Mucin 1 Market Drivers
13.3 Mucin 1 Market Challenges
13.4 Mucin 1 Market Restraints
14 Key Findings in The Global Mucin 1 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Mucin 1 Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of TG-4010
Table 3. Major Manufacturers of GO-2032c
Table 4. Major Manufacturers of ImMucin
Table 5. Major Manufacturers of BI-1361849
Table 6. Major Manufacturers of Others
Table 7. Global Mucin 1 Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Mucin 1 Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global Mucin 1 Revenue by Region (2019-2024) & (US$ Million)
Table 10. Global Mucin 1 Revenue by Region (2025-2030) & (US$ Million)
Table 11. Global Mucin 1 Revenue Market Share by Region (2019-2024)
Table 12. Global Mucin 1 Revenue Market Share by Region (2025-2030)
Table 13. Global Mucin 1 Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Mucin 1 Sales by Region (2019-2024) & (K Pcs)
Table 15. Global Mucin 1 Sales by Region (2025-2030) & (K Pcs)
Table 16. Global Mucin 1 Sales Market Share by Region (2019-2024)
Table 17. Global Mucin 1 Sales Market Share by Region (2025-2030)
Table 18. Global Mucin 1 Sales by Manufacturers (2019-2024) & (K Pcs)
Table 19. Global Mucin 1 Sales Share by Manufacturers (2019-2024)
Table 20. Global Mucin 1 Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 21. Global Mucin 1 Revenue Share by Manufacturers (2019-2024)
Table 22. Global Key Players of Mucin 1, Industry Ranking, 2022 VS 2023 VS 2024
Table 23. Mucin 1 Price by Manufacturers 2019-2024 (USD/Pcs)
Table 24. Global Mucin 1 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Mucin 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucin 1 as of 2023)
Table 26. Global Key Manufacturers of Mucin 1, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Mucin 1, Product Offered and Application
Table 28. Global Key Manufacturers of Mucin 1, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Mucin 1 Sales by Type (2019-2024) & (K Pcs)
Table 31. Global Mucin 1 Sales by Type (2025-2030) & (K Pcs)
Table 32. Global Mucin 1 Sales Share by Type (2019-2024)
Table 33. Global Mucin 1 Sales Share by Type (2025-2030)
Table 34. Global Mucin 1 Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Mucin 1 Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Mucin 1 Revenue Share by Type (2019-2024)
Table 37. Global Mucin 1 Revenue Share by Type (2025-2030)
Table 38. Mucin 1 Price by Type (2019-2024) & (USD/Pcs)
Table 39. Global Mucin 1 Price Forecast by Type (2025-2030) & (USD/Pcs)
Table 40. Global Mucin 1 Sales by Application (2019-2024) & (K Pcs)
Table 41. Global Mucin 1 Sales by Application (2025-2030) & (K Pcs)
Table 42. Global Mucin 1 Sales Share by Application (2019-2024)
Table 43. Global Mucin 1 Sales Share by Application (2025-2030)
Table 44. Global Mucin 1 Revenue by Application (2019-2024) & (US$ Million)
Table 45. Global Mucin 1 Revenue by Application (2025-2030) & (US$ Million)
Table 46. Global Mucin 1 Revenue Share by Application (2019-2024)
Table 47. Global Mucin 1 Revenue Share by Application (2025-2030)
Table 48. Mucin 1 Price by Application (2019-2024) & (USD/Pcs)
Table 49. Global Mucin 1 Price Forecast by Application (2025-2030) & (USD/Pcs)
Table 50. US & Canada Mucin 1 Sales by Type (2019-2024) & (K Pcs)
Table 51. US & Canada Mucin 1 Sales by Type (2025-2030) & (K Pcs)
Table 52. US & Canada Mucin 1 Revenue by Type (2019-2024) & (US$ Million)
Table 53. US & Canada Mucin 1 Revenue by Type (2025-2030) & (US$ Million)
Table 54. US & Canada Mucin 1 Sales by Application (2019-2024) & (K Pcs)
Table 55. US & Canada Mucin 1 Sales by Application (2025-2030) & (K Pcs)
Table 56. US & Canada Mucin 1 Revenue by Application (2019-2024) & (US$ Million)
Table 57. US & Canada Mucin 1 Revenue by Application (2025-2030) & (US$ Million)
Table 58. US & Canada Mucin 1 Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. US & Canada Mucin 1 Revenue by Country (2019-2024) & (US$ Million)
Table 60. US & Canada Mucin 1 Revenue by Country (2025-2030) & (US$ Million)
Table 61. US & Canada Mucin 1 Sales by Country (2019-2024) & (K Pcs)
Table 62. US & Canada Mucin 1 Sales by Country (2025-2030) & (K Pcs)
Table 63. Europe Mucin 1 Sales by Type (2019-2024) & (K Pcs)
Table 64. Europe Mucin 1 Sales by Type (2025-2030) & (K Pcs)
Table 65. Europe Mucin 1 Revenue by Type (2019-2024) & (US$ Million)
Table 66. Europe Mucin 1 Revenue by Type (2025-2030) & (US$ Million)
Table 67. Europe Mucin 1 Sales by Application (2019-2024) & (K Pcs)
Table 68. Europe Mucin 1 Sales by Application (2025-2030) & (K Pcs)
Table 69. Europe Mucin 1 Revenue by Application (2019-2024) & (US$ Million)
Table 70. Europe Mucin 1 Revenue by Application (2025-2030) & (US$ Million)
Table 71. Europe Mucin 1 Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 72. Europe Mucin 1 Revenue by Country (2019-2024) & (US$ Million)
Table 73. Europe Mucin 1 Revenue by Country (2025-2030) & (US$ Million)
Table 74. Europe Mucin 1 Sales by Country (2019-2024) & (K Pcs)
Table 75. Europe Mucin 1 Sales by Country (2025-2030) & (K Pcs)
Table 76. China Mucin 1 Sales by Type (2019-2024) & (K Pcs)
Table 77. China Mucin 1 Sales by Type (2025-2030) & (K Pcs)
Table 78. China Mucin 1 Revenue by Type (2019-2024) & (US$ Million)
Table 79. China Mucin 1 Revenue by Type (2025-2030) & (US$ Million)
Table 80. China Mucin 1 Sales by Application (2019-2024) & (K Pcs)
Table 81. China Mucin 1 Sales by Application (2025-2030) & (K Pcs)
Table 82. China Mucin 1 Revenue by Application (2019-2024) & (US$ Million)
Table 83. China Mucin 1 Revenue by Application (2025-2030) & (US$ Million)
Table 84. Asia Mucin 1 Sales by Type (2019-2024) & (K Pcs)
Table 85. Asia Mucin 1 Sales by Type (2025-2030) & (K Pcs)
Table 86. Asia Mucin 1 Revenue by Type (2019-2024) & (US$ Million)
Table 87. Asia Mucin 1 Revenue by Type (2025-2030) & (US$ Million)
Table 88. Asia Mucin 1 Sales by Application (2019-2024) & (K Pcs)
Table 89. Asia Mucin 1 Sales by Application (2025-2030) & (K Pcs)
Table 90. Asia Mucin 1 Revenue by Application (2019-2024) & (US$ Million)
Table 91. Asia Mucin 1 Revenue by Application (2025-2030) & (US$ Million)
Table 92. Asia Mucin 1 Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 93. Asia Mucin 1 Revenue by Region (2019-2024) & (US$ Million)
Table 94. Asia Mucin 1 Revenue by Region (2025-2030) & (US$ Million)
Table 95. Asia Mucin 1 Sales by Region (2019-2024) & (K Pcs)
Table 96. Asia Mucin 1 Sales by Region (2025-2030) & (K Pcs)
Table 97. Middle East, Africa and Latin America Mucin 1 Sales by Type (2019-2024) & (K Pcs)
Table 98. Middle East, Africa and Latin America Mucin 1 Sales by Type (2025-2030) & (K Pcs)
Table 99. Middle East, Africa and Latin America Mucin 1 Revenue by Type (2019-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Mucin 1 Revenue by Type (2025-2030) & (US$ Million)
Table 101. Middle East, Africa and Latin America Mucin 1 Sales by Application (2019-2024) & (K Pcs)
Table 102. Middle East, Africa and Latin America Mucin 1 Sales by Application (2025-2030) & (K Pcs)
Table 103. Middle East, Africa and Latin America Mucin 1 Revenue by Application (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Mucin 1 Revenue by Application (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Mucin 1 Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 106. Middle East, Africa and Latin America Mucin 1 Revenue by Country (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Mucin 1 Revenue by Country (2025-2030) & (US$ Million)
Table 108. Middle East, Africa and Latin America Mucin 1 Sales by Country (2019-2024) & (K Pcs)
Table 109. Middle East, Africa and Latin America Mucin 1 Sales by Country (2025-2030) & (K Pcs)
Table 110. Akshaya Bio Inc Company Information
Table 111. Akshaya Bio Inc Description and Major Businesses
Table 112. Akshaya Bio Inc Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. Akshaya Bio Inc Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Akshaya Bio Inc Recent Developments
Table 115. Bavarian Nordic A/S Company Information
Table 116. Bavarian Nordic A/S Description and Major Businesses
Table 117. Bavarian Nordic A/S Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Bavarian Nordic A/S Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bavarian Nordic A/S Recent Developments
Table 120. Boehringer Ingelheim GmbH Company Information
Table 121. Boehringer Ingelheim GmbH Description and Major Businesses
Table 122. Boehringer Ingelheim GmbH Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Boehringer Ingelheim GmbH Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Boehringer Ingelheim GmbH Recent Developments
Table 125. Etubics Corp Company Information
Table 126. Etubics Corp Description and Major Businesses
Table 127. Etubics Corp Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 128. Etubics Corp Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Etubics Corp Recent Developments
Table 130. GeoVax Labs Inc Company Information
Table 131. GeoVax Labs Inc Description and Major Businesses
Table 132. GeoVax Labs Inc Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 133. GeoVax Labs Inc Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. GeoVax Labs Inc Recent Developments
Table 135. Merck KGaA Company Information
Table 136. Merck KGaA Description and Major Businesses
Table 137. Merck KGaA Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 138. Merck KGaA Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Merck KGaA Recent Developments
Table 140. Minerva Biotechnologies Corp Company Information
Table 141. Minerva Biotechnologies Corp Description and Major Businesses
Table 142. Minerva Biotechnologies Corp Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 143. Minerva Biotechnologies Corp Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Minerva Biotechnologies Corp Recent Developments
Table 145. Transgene SA Company Information
Table 146. Transgene SA Description and Major Businesses
Table 147. Transgene SA Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 148. Transgene SA Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Transgene SA Recent Developments
Table 150. Vaxil Bio Therapeutics Ltd Company Information
Table 151. Vaxil Bio Therapeutics Ltd Description and Major Businesses
Table 152. Vaxil Bio Therapeutics Ltd Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 153. Vaxil Bio Therapeutics Ltd Mucin 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Vaxil Bio Therapeutics Ltd Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Mucin 1 Distributors List
Table 158. Mucin 1 Customers List
Table 159. Mucin 1 Market Trends
Table 160. Mucin 1 Market Drivers
Table 161. Mucin 1 Market Challenges
Table 162. Mucin 1 Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Mucin 1 Product Picture
Figure 2. Global Mucin 1 Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Mucin 1 Market Share by Type in 2023 & 2030
Figure 4. TG-4010 Product Picture
Figure 5. GO-2032c Product Picture
Figure 6. ImMucin Product Picture
Figure 7. BI-1361849 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Mucin 1 Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global Mucin 1 Market Share by Application in 2023 & 2030
Figure 11. Prostate Cancer
Figure 12. Breast Cancer
Figure 13. Colon Cancer
Figure 14. Ovarian Cancer
Figure 15. Others
Figure 16. Mucin 1 Report Years Considered
Figure 17. Global Mucin 1 Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Mucin 1 Revenue 2019-2030 (US$ Million)
Figure 19. Global Mucin 1 Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 20. Global Mucin 1 Revenue Market Share by Region (2019-2030)
Figure 21. Global Mucin 1 Sales 2019-2030 ((K Pcs)
Figure 22. Global Mucin 1 Sales Market Share by Region (2019-2030)
Figure 23. US & Canada Mucin 1 Sales YoY (2019-2030) & (K Pcs)
Figure 24. US & Canada Mucin 1 Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Europe Mucin 1 Sales YoY (2019-2030) & (K Pcs)
Figure 26. Europe Mucin 1 Revenue YoY (2019-2030) & (US$ Million)
Figure 27. China Mucin 1 Sales YoY (2019-2030) & (K Pcs)
Figure 28. China Mucin 1 Revenue YoY (2019-2030) & (US$ Million)
Figure 29. Asia (excluding China) Mucin 1 Sales YoY (2019-2030) & (K Pcs)
Figure 30. Asia (excluding China) Mucin 1 Revenue YoY (2019-2030) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Mucin 1 Sales YoY (2019-2030) & (K Pcs)
Figure 32. Middle East, Africa and Latin America Mucin 1 Revenue YoY (2019-2030) & (US$ Million)
Figure 33. The Mucin 1 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 34. The Top 5 and 10 Largest Manufacturers of Mucin 1 in the World: Market Share by Mucin 1 Revenue in 2023
Figure 35. Global Mucin 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 36. Global Mucin 1 Sales Market Share by Type (2019-2030)
Figure 37. Global Mucin 1 Revenue Market Share by Type (2019-2030)
Figure 38. Global Mucin 1 Sales Market Share by Application (2019-2030)
Figure 39. Global Mucin 1 Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Mucin 1 Sales Market Share by Type (2019-2030)
Figure 41. US & Canada Mucin 1 Revenue Market Share by Type (2019-2030)
Figure 42. US & Canada Mucin 1 Sales Market Share by Application (2019-2030)
Figure 43. US & Canada Mucin 1 Revenue Market Share by Application (2019-2030)
Figure 44. US & Canada Mucin 1 Revenue Share by Country (2019-2030)
Figure 45. US & Canada Mucin 1 Sales Share by Country (2019-2030)
Figure 46. U.S. Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 47. Canada Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 48. Europe Mucin 1 Sales Market Share by Type (2019-2030)
Figure 49. Europe Mucin 1 Revenue Market Share by Type (2019-2030)
Figure 50. Europe Mucin 1 Sales Market Share by Application (2019-2030)
Figure 51. Europe Mucin 1 Revenue Market Share by Application (2019-2030)
Figure 52. Europe Mucin 1 Revenue Share by Country (2019-2030)
Figure 53. Europe Mucin 1 Sales Share by Country (2019-2030)
Figure 54. Germany Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 55. France Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 56. U.K. Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 57. Italy Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 58. Russia Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 59. China Mucin 1 Sales Market Share by Type (2019-2030)
Figure 60. China Mucin 1 Revenue Market Share by Type (2019-2030)
Figure 61. China Mucin 1 Sales Market Share by Application (2019-2030)
Figure 62. China Mucin 1 Revenue Market Share by Application (2019-2030)
Figure 63. Asia Mucin 1 Sales Market Share by Type (2019-2030)
Figure 64. Asia Mucin 1 Revenue Market Share by Type (2019-2030)
Figure 65. Asia Mucin 1 Sales Market Share by Application (2019-2030)
Figure 66. Asia Mucin 1 Revenue Market Share by Application (2019-2030)
Figure 67. Asia Mucin 1 Revenue Share by Region (2019-2030)
Figure 68. Asia Mucin 1 Sales Share by Region (2019-2030)
Figure 69. Japan Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 70. South Korea Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 71. China Taiwan Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 72. Southeast Asia Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 73. India Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Mucin 1 Sales Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America Mucin 1 Revenue Market Share by Type (2019-2030)
Figure 76. Middle East, Africa and Latin America Mucin 1 Sales Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America Mucin 1 Revenue Market Share by Application (2019-2030)
Figure 78. Middle East, Africa and Latin America Mucin 1 Revenue Share by Country (2019-2030)
Figure 79. Middle East, Africa and Latin America Mucin 1 Sales Share by Country (2019-2030)
Figure 80. Brazil Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 81. Mexico Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 82. Turkey Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 83. Israel Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 84. GCC Countries Mucin 1 Revenue (2019-2030) & (US$ Million)
Figure 85. Mucin 1 Value Chain
Figure 86. Mucin 1 Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Mucin 1 market?
The top companies in the global Mucin 1 market are Akshaya Bio Inc、Bavarian Nordic A/S、Boehringer Ingelheim GmbH.
Related Reports
Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mucin 1 was estimated to be worth US$ 300 million in 2025 and is projected to reach US$ 620 million, growing at a CAGR of 10.8% from 2026 to 2032.
Published Date: 2026-05-30
Pages: 193
USD 3950.00
(Single User License)
Global Mucin 1 Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mucin 1 market is projected to grow from US$ 300 million in 2025 to US$ 620 million by 2032, at a CAGR of 10.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-05-30
Pages: 240
USD 4900.00
(Single User License)
Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mucin 1 market size was US$ 300 million in 2025 and is forecast to reach a readjusted size of US$ 620 million by 2032 with a CAGR of 10.8% during the forecast period 2026-2032.
Published Date: 2026-05-30
Pages: 187
USD 4250.00
(Single User License)
Global Mucin 1 Market Research Report 2026
The global Mucin 1 market was valued at US$ 300 million in 2025 and is anticipated to reach US$ 620 million by 2032, at a CAGR of 10.8% from 2026 to 2032.
Published Date: 2026-05-30
Pages: 175
USD 2900.00
(Single User License)
Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mucin 1 market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 78
USD 4250.00
(Single User License)
Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mucin 1 was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 94
USD 3950.00
(Single User License)
Global Mucin 1 Market Research Report 2025
The global market for Mucin 1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 87
USD 2900.00
(Single User License)
Global Mucin 1 Market Research Report 2024
The global Mucin 1 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-08
Pages: 81
USD 2900.00
(Single User License)
Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mucin 1 was estimated to be worth US$ 300 million in 2025 and is projected to reach US$ 620 million, growing at a CAGR of 10.8% from 2026 to 2032.
Published: 2026-05-30
Pages: 193
USD 3950.00 (Single User License)Global Mucin 1 Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mucin 1 market is projected to grow from US$ 300 million in 2025 to US$ 620 million by 2032, at a CAGR of 10.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-05-30
Pages: 240
USD 4900.00 (Single User License)Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mucin 1 market size was US$ 300 million in 2025 and is forecast to reach a readjusted size of US$ 620 million by 2032 with a CAGR of 10.8% during the forecast period 2026-2032.
Published: 2026-05-30
Pages: 187
USD 4250.00 (Single User License)Global Mucin 1 Market Research Report 2026
The global Mucin 1 market was valued at US$ 300 million in 2025 and is anticipated to reach US$ 620 million by 2032, at a CAGR of 10.8% from 2026 to 2032.
Published: 2026-05-30
Pages: 175
USD 2900.00 (Single User License)Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mucin 1 market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 78
USD 4250.00 (Single User License)Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mucin 1 was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 94
USD 3950.00 (Single User License)Global Mucin 1 Market Research Report 2025
The global market for Mucin 1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 87
USD 2900.00 (Single User License)Global Mucin 1 Market Research Report 2024
The global Mucin 1 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-08
Pages: 81
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now